08:42 AM EST, 02/06/2025 (MT Newswires) -- Embecta ( EMBC ) reported fiscal Q1 adjusted earnings Thursday of $0.65 per diluted share, up from $0.61 a year earlier.

Analysts polled by FactSet expected $0.44.

Revenue for the quarter ended Dec. 31 was $261.9 million, down from $277.3 million a year earlier.

Analysts surveyed by FactSet expected $254.6 million.

The medical device company said it continues to expect 2025 adjusted EPS of $2.70 to $2.90. Analysts polled by FactSet expect $2.80.

Revenue for the fiscal year is now expected to be $1.08 billion to $1.09 billion, compared with prior guidance of between $1.09 billion and $1.11 billion. Analysts surveyed by FactSet expect $1.10 billion.